149 related articles for article (PubMed ID: 31014686)
1. Driving and Visual Acuity in Patients with Age-Related Macular Degeneration.
Patnaik JL; Pecen PE; Hanson K; Lynch AM; Cathcart JN; Siringo FS; Mathias MT; Mandava N
Ophthalmol Retina; 2019 Apr; 3(4):336-342. PubMed ID: 31014686
[TBL] [Abstract][Full Text] [Related]
2. Driving habits in older patients with central vision loss.
Sengupta S; van Landingham SW; Solomon SD; Do DV; Friedman DS; Ramulu PY
Ophthalmology; 2014 Mar; 121(3):727-32. PubMed ID: 24290805
[TBL] [Abstract][Full Text] [Related]
3. Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Chakravarthy U; Bailey CC; Johnston RL; McKibbin M; Khan RS; Mahmood S; Downey L; Dhingra N; Brand C; Brittain CJ; Willis JR; Rabhi S; Muthutantri A; Cantrell RA
Ophthalmology; 2018 Jun; 125(6):842-849. PubMed ID: 29366564
[TBL] [Abstract][Full Text] [Related]
4. Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts.
Falkenstein IA; Cochran DE; Azen SP; Dustin L; Tammewar AM; Kozak I; Freeman WR
Ophthalmology; 2008 Feb; 115(2):319-23. PubMed ID: 17706288
[TBL] [Abstract][Full Text] [Related]
5. Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
Bressler NM; Chang TS; Varma R; Suñer I; Lee P; Dolan CM; Ward J; Ianchulev T; Fine J
Ophthalmology; 2013 Jan; 120(1):160-8. PubMed ID: 23009891
[TBL] [Abstract][Full Text] [Related]
6. Mental health and visual acuity in patients with age-related macular degeneration.
Fonteh CN; Mathias MT; Mandava N; Manoharan N; Lynch AM; Navo R; Patnaik JL;
BMC Ophthalmol; 2022 Oct; 22(1):391. PubMed ID: 36183081
[TBL] [Abstract][Full Text] [Related]
7. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.
Wong TY; Chakravarthy U; Klein R; Mitchell P; Zlateva G; Buggage R; Fahrbach K; Probst C; Sledge I
Ophthalmology; 2008 Jan; 115(1):116-26. PubMed ID: 17675159
[TBL] [Abstract][Full Text] [Related]
8. Early age-related maculopathy and self-reported visual difficulty in daily life.
Scilley K; Jackson GR; Cideciyan AV; Maguire MG; Jacobson SG; Owsley C
Ophthalmology; 2002 Jul; 109(7):1235-42. PubMed ID: 12093644
[TBL] [Abstract][Full Text] [Related]
9. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.
Mruthyunjaya P; Stinnett SS; Toth CA
Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing between Better and Worse Visual Acuity by Studying the Correlation with Quality of Life in Neovascular Age-Related Macular Degeneration.
Elshout M; van der Reis MI; de Jong-Hesse Y; Webers CA; Schouten JS
Ophthalmology; 2016 Nov; 123(11):2408-2412. PubMed ID: 27568997
[TBL] [Abstract][Full Text] [Related]
11. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
Cahill MT; Banks AD; Stinnett SS; Toth CA
Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
[TBL] [Abstract][Full Text] [Related]
12. Effects of Age-Related Macular Degeneration on Driving Performance.
Wood JM; Black AA; Mallon K; Kwan AS; Owsley C
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):273-279. PubMed ID: 29340641
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK.
Wolowacz SE; Roskell N; Kelly S; Maciver FM; Brand CS
Pharmacoeconomics; 2007; 25(10):863-79. PubMed ID: 17887807
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.
Lindblad AS; Clemons TE
Arch Ophthalmol; 2005 Sep; 123(9):1207-14. PubMed ID: 16157800
[TBL] [Abstract][Full Text] [Related]
15. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
Bandello F; Lafuma A; Berdeaux G
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
[TBL] [Abstract][Full Text] [Related]
16. Visual acuity loss in patients with age-related macular degeneration measured using a novel high-pass letter chart.
Shah N; Dakin SC; Dobinson S; Tufail A; Egan CA; Anderson RS
Br J Ophthalmol; 2016 Oct; 100(10):1346-52. PubMed ID: 26846435
[TBL] [Abstract][Full Text] [Related]
17. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.
Sunness JS; Gonzalez-Baron J; Applegate CA; Bressler NM; Tian Y; Hawkins B; Barron Y; Bergman A
Ophthalmology; 1999 Sep; 106(9):1768-79. PubMed ID: 10485549
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study.
Matamoros E; Maurel F; Léon N; Solomiac A; Bardoulat I; Joubert M; Hermans M; Moser E; Le Picard S; Souied EH; Leveziel N
Ophthalmologica; 2015; 234(3):151-9. PubMed ID: 26337381
[TBL] [Abstract][Full Text] [Related]
19. Impaired mesopic visual acuity in eyes with early age-related macular degeneration.
Puell MC; Barrio AR; Palomo-Alvarez C; Gómez-Sanz FJ; Clement-Corral A; Pérez-Carrasco MJ
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7310-4. PubMed ID: 23033386
[TBL] [Abstract][Full Text] [Related]
20. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
Orr P; Rentz AM; Margolis MK; Revicki DA; Dolan CM; Colman S; Fine JT; Bressler NM
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3354-9. PubMed ID: 21282568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
